Taraboletti G, Belotti D, Dejana E, Mantovani A, Giavazzi R
Istituto di Ricerche Farmacologiche Mario Negri, Bergamo, Italy.
Cancer Res. 1993 Aug 15;53(16):3812-6.
Polyoma virus middle T-transformed murine endothelioma cell lines provide a useful model for studying vascular lesions such as hemangiomas, hemangiosarcomas, and Kaposi's sarcoma and tumor-associated angiogenesis. In vivo they produce fast-growing, hemorrhaging, cavernous blood-filled hemangiomas, mainly formed by recruited host endothelial cells, suggesting an angiogenesis-like process underlying the lesion. The molecular mechanism(s) responsible for the recruitment of host endothelial cells by endothelioma cells has not yet been identified. We found that five different cultured endothelioma cell lines produced a soluble factor, named endothelioma-derived motility factor (EDMF) that stimulates chemotaxis (motility induced by a gradient of soluble attractant), haptotaxis (motility in response to substrate-bound attractant), and chemoinvasion (migration through a layer of reconstituted basement membrane, Matrigel) of normal human, bovine, and murine endothelial cells. The inhibitory effect of actinomycin D and of enzymatic treatment on its activity proved that EDMF is a protein. EDMF binds to heparin, since its activity was inhibited by heparin, and it was retained on a heparin-Sepharose column. Its molecular weight, as assessed by Sephacryl S-200 gel filtration, ranges from 40,000-65,000. Although in many aspects EDMF is similar to vascular permeability factor-vascular endothelial growth factor, this was not detected in endothelioma cell supernatants, as assessed by enzyme-linked immunosorbent assay, thus indicating that EDMF might be related to, but is not identical with, vascular permeability factor. Our findings support the notion that recruitment of host endothelial cells by endothelioma cells in vivo might be mediated by a still unidentified, soluble factor that stimulates and directs endothelial cell migration.
多瘤病毒中T抗原转化的鼠内皮瘤细胞系为研究诸如血管瘤、血管肉瘤和卡波西肉瘤等血管病变以及肿瘤相关血管生成提供了一个有用的模型。在体内,它们会产生快速生长、出血的海绵状充血性血管瘤,主要由募集的宿主内皮细胞形成,这表明该病变背后存在类似血管生成的过程。内皮瘤细胞募集宿主内皮细胞的分子机制尚未明确。我们发现五种不同的培养内皮瘤细胞系产生了一种可溶性因子,命名为内皮瘤衍生运动因子(EDMF),它能刺激正常人、牛和鼠内皮细胞的趋化作用(由可溶性吸引剂梯度诱导的运动)、趋触性(对底物结合吸引剂的反应运动)和化学侵袭(穿过一层重组基底膜基质胶的迁移)。放线菌素D和酶处理对其活性的抑制作用证明EDMF是一种蛋白质。EDMF与肝素结合,因为其活性被肝素抑制,并且它能保留在肝素 - 琼脂糖柱上。通过Sephacryl S - 200凝胶过滤评估,其分子量范围为40,000 - 65,000。尽管在许多方面EDMF与血管通透性因子 - 血管内皮生长因子相似,但通过酶联免疫吸附测定评估,在内皮瘤细胞上清液中未检测到该因子,因此表明EDMF可能与血管通透性因子相关,但并不相同。我们的研究结果支持这样一种观点,即体内内皮瘤细胞募集宿主内皮细胞可能是由一种尚未明确的可溶性因子介导的,该因子刺激并指导内皮细胞迁移。